EUVIMEDOpdag EUVIMED
Crossref

Benzothiazole–Triphenylphosphonium Conjugates: Synthesis, In Silico Analysis, and Exploratory In Vitro Effects on HT‐29 Colorectal Cancer Cell Viability

Fatima E Laghchioua, Ana T P C Gomes iD, Karina Mendes iD, Ricardo F Mendes, Filipe A Almeida Paz, Paula A Videira, M Amparo F Faustino iD, José A S Cavaleiro, El Mostapha Rakib, Maria Graça P M S Neves, Florbela Pereira iD, Nuno M M Moura

ChemMedChem · 2026

DOI: 10.1002/cmdc.70382 ↗

At a glance

Journal article in ChemMedChem, 2026. Written by Fatima E Laghchioua and 11 co-authors. Institution: Laboratory of Molecular Chemistry, Materials and Catalysis, Faculty of Sciences and Technics, Sultan Moulay Slimane University, Beni-Mellal, Morocco. Major MEDLINE topics: Benzothiazoles, Organophosphorus Compounds, Antineoplastic Agents. Cited 1 times so far (Crossref); 86 references. Funded by: University of Aveiro, Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES), Agência Nacional da Inovação (ANI).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

A series of (2‐((6‐benzo[ d ]thiazol‐2‐yl)amino)‐2‐oxoethyl)triphenylphosphonium (TPP) derivatives ( 4a – f ) was synthesised and evaluated in a colorectal cancer (CRC) cell model. Compounds were obtained in high yields via acylation of aminobenzothiazoles with chloroacetyl chloride, followed by quaternization with triphenylphosphine. A computer‐aided drug‐design approach combining quantitative structure–activity relationship, molecular docking, and molecular dynamics simulations was used to guide prioritization and explore putative protein–ligand interactions in silico. Antiproliferative effects of conjugates 4a–f on cell viability were assessed in HT‐29 human CRC cells (mutant p53 model), using a resazurin viability assay. Compounds 4b and 4c showed concentration‐responsive activity, with IC 50 values of 174 and 153 µM, respectively, identifying them as the most active derivatives in this preliminary phenotypic screen. Gene expression analysis showed upregulation of p21 mRNA, while MDM2 mRNA showed minimal changes, providing preliminary transcript‐level observations in response to compound exposure. As all assays were performed in p53‐mutant HT‐29 cells, these effects are interpreted as exploratory stress‐related responses rather than evidence of wild‐type p53 pathway reactivation or direct inhibition of the p53–MDM2 interaction. The study provides an integrated workflow combining synthesis of an unreported benzothiazole–TPP scaffold, computational prioritization, and preliminary biological evaluation. Despite modest antiproliferative activity, results identify initial structure–activity trends within the series, establishing a foundation for future optimisation.

Subjects

MeSH terms (MEDLINE)

BenzothiazolesOrganophosphorus CompoundsAntineoplastic AgentsHumansCell SurvivalCell ProliferationDrug Screening Assays, AntitumorHT29 CellsMolecular Docking SimulationQuantitative Structure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugColorectal NeoplasmsProto-Oncogene Proteins c-mdm2Molecular Dynamics SimulationStructure-Activity Relationship

Author keywords

triphenylphosphoniumHT‐29Quantitative Structure–Activity Relationships (QSAR)benzothiazolecell viabilitygene expressionmolecular docking

Substances

BenzothiazolesOrganophosphorus CompoundsAntineoplastic AgentsbenzothiazoletriphenylphosphineProto-Oncogene Proteins c-mdm2triphenylphosphonium

Authors and institutions

  • Laboratory of Molecular Chemistry, Materials and Catalysis, Faculty of Sciences and Technics, Sultan Moulay Slimane University, Beni-Mellal, Morocco.
  • LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
  • Faculdade de Medicina Dentária, Centro de Investigação Interdisciplinar em Saúde, Universidade Católica Portuguesa, Viseu, Portugal.
  • Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Aveiro, Portugal.
  • UCIBIO - Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, Caparica, Portugal.
  • Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, Caparica, Portugal.

ORCID profiles: Ana T P C Gomes, Karina Mendes, M Amparo F Faustino, Florbela Pereira

Funding

  • University of Aveiro
  • Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES)
  • Agência Nacional da Inovação (ANI)
  • FCT

Cite

APA

Laghchioua, F. E., Gomes, A. T. P. C., Mendes, K., Mendes, R. F., Paz, F. A. A., Videira, P. A., Faustino, M. A. F., Cavaleiro, J. A. S., Rakib, E. M., Neves, M. G. P. M. S., Pereira, F., & Moura, N. M. M. (2026). Benzothiazole–Triphenylphosphonium Conjugates: Synthesis, In Silico Analysis, and Exploratory In Vitro Effects on HT‐29 Colorectal Cancer Cell Viability. ChemMedChem. https://doi.org/10.1002/cmdc.70382

Vancouver

Laghchioua FE, Gomes ATPC, Mendes K, Mendes RF, Paz FAA, Videira PA, et al. Benzothiazole–Triphenylphosphonium Conjugates: Synthesis, In Silico Analysis, and Exploratory In Vitro Effects on HT‐29 Colorectal Cancer Cell Viability. ChemMedChem. 2026. doi:10.1002/cmdc.70382

BibTeX
@article{Laghchioua2026,
  author = {Laghchioua, Fatima E and Gomes, Ana T P C and Mendes, Karina and Mendes, Ricardo F and Paz, Filipe A Almeida and Videira, Paula A and Faustino, M Amparo F and Cavaleiro, José A S and Rakib, El Mostapha and Neves, Maria Graça P M S and Pereira, Florbela and Moura, Nuno M M},
  title = {Benzothiazole–Triphenylphosphonium Conjugates: Synthesis, In Silico Analysis, and Exploratory In Vitro Effects on HT‐29 Colorectal Cancer Cell Viability},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70382}
}
Start for free →